NDT Pharmaceuticals Showcases Strategic Value of Good Salt(TM) Life Acquisition with Expanded Relationship with Norwegian Cruise Line
Accessnewswire·2025-10-21 12:30
ATHENS, GEORGIA / ACCESS Newswire / October 21, 2025 / NDT Pharmaceuticals Inc. (OTC PINK:NDTP), a company focused on advancing innovative consumer health and wellness solutions, today announced a major post-acquisition milestone with the expanded relationship between its subsidiary, Good Saltâ"¢ Life, Inc., and Norwegian Cruise Line (NCL). Following NDT Pharmaceuticals' acquisition of Good Salt Life on September 5, 2025, the subsidiary has deepened its long-standing relationship with NCL, which has placed ...